Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - Arena Pharmaceuticals: A Speculative Buy To Play The Upcoming Etrasimod's Data-Readout

PFE - Arena Pharmaceuticals: A Speculative Buy To Play The Upcoming Etrasimod's Data-Readout

Pfizer Inc.
  • After the recent FDA black box warning of JAKi, Arena Pharmaceuticals' share price has rallied recovering some of its 2021 losses.
  • In this article, Etrasimod's ulcerative colitis phase 2 data will be analyzed and explain what our views for the S1P-R class moving forward.
  • Arena Pharmaceuticals may deserve an option size position to play the upcoming CD (Q4 2021) and UC data (Q1 2022).
  • We believe class-wide cardiovascular adverse events may plague the whole S1P-R class as more molecules enter larger phase 3 trials and Zeposia's RWE data arises.

For further details see:

Arena Pharmaceuticals: A Speculative Buy To Play The Upcoming Etrasimod's Data-Readout
Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...